Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Revenue (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Revenue for 13 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue fell 38.31% to $3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.8 million, a 28.6% decrease, with the full-year FY2025 number at $12.8 million, down 28.6% from a year prior.
  • Revenue was $3.1 million for Q4 2025 at Ekso Bionics Holdings, down from $4.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $5.1 million in Q4 2024 to a low of $1.9 million in Q1 2021.
  • A 5-year average of $3.6 million and a median of $3.6 million in 2022 define the central range for Revenue.
  • Peak YoY movement for Revenue: soared 60.58% in 2023, then plummeted 58.44% in 2025.
  • Ekso Bionics Holdings' Revenue stood at $3.0 million in 2021, then increased by 16.46% to $3.6 million in 2022, then skyrocketed by 36.5% to $4.8 million in 2023, then rose by 5.01% to $5.1 million in 2024, then plummeted by 38.31% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Revenue are $3.1 million (Q4 2025), $4.2 million (Q3 2025), and $2.1 million (Q2 2025).